Guiding principles of good AI practice in drug development By VICT3R|2026-02-02T10:01:38+02:00February 26th, 2025| Read More
Virtual Control Groups in Nonclinical Research: A Re-analysis of 20 Studies Using Virtual Control Group Data By VICT3R|2026-03-02T17:26:26+02:00February 26th, 2025| Read More
The age of animal experiments is waning. Where will science go next? By VICT3R|2026-03-02T17:28:59+02:00February 26th, 2025| Read More
Never-ending Acronym Madness: Proposing a harmonized definition for NAMs By VICT3R|2026-03-23T12:58:35+02:00February 25th, 2025| Read More
Analysis of rat toxicology studies: statistical agreement between virtual and concurrent controls in detecting treatment effects on liver enzymes By VICT3R|2026-05-04T18:17:54+02:00February 25th, 2025| Read More
AI snake oil? A risk/benefit analysis for toxicology By VICT3R|2026-05-28T09:38:36+02:00February 7th, 2024| Read More